8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Oct 22, 2019)

Filed October 22, 2019For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on October 22, 2019, to announce its financial results for the third quarter ended September 30, 2019. This filing primarily incorporates by reference a press release detailing the company's performance during the period. Investors should review the attached press release for specific financial figures, operational updates, and any forward-looking statements made by the company. While the 8-K itself is brief, it signals that Quest Diagnostics has disclosed key performance indicators relevant to its business segments, revenue generation, and profitability. Investors looking for details on earnings per share, revenue growth, segment performance, and management's outlook on future performance will need to examine the referenced press release (Exhibit 99.1) thoroughly. This report serves as the official notification of the company's quarterly performance update.

Key Highlights

  • 1Quest Diagnostics announced its financial results for the third quarter ended September 30, 2019, via an 8-K filing.
  • 2The primary content of the 8-K is the incorporation of a press release (Exhibit 99.1) detailing Q3 2019 results.
  • 3Investors need to consult the press release for specific financial data, including revenue, earnings, and operational metrics.
  • 4The filing serves as official confirmation of the company's quarterly performance announcement.
  • 5No new material financial statements or specific disclosures beyond the press release content are presented in the 8-K itself.
  • 6The report confirms the date of the earnings announcement was October 22, 2019.

Frequently Asked Questions

The 8-K filing itself does not contain the specific financial results. Investors must refer to Exhibit 99.1, the press release dated October 22, 2019, which is incorporated by reference, for detailed information on revenue, earnings per share, and other key financial metrics for the quarter ended September 30, 2019.

This 8-K filing formally announces and makes publicly available Quest Diagnostics' third-quarter financial results. It provides investors with the official channel to access the company's performance update and any forward-looking statements made by management.

While the press release is the primary source of detailed Q3 2019 financial information referenced in this 8-K, investors should also look for subsequent filings like the Form 10-Q, which will contain audited financial statements and a more comprehensive Management's Discussion and Analysis (MD&A) for the period.